BiF-4 Insights – Deborah Brooks – Michael J. Fox Foundation

We want to de-risk ideas and help move them towards being taken into clinical trials.

We sometimes add money to company investments in order to make Phase 1 trials more robust than originally planned:

  • $4 million VC-funded trial, we incremented by $750k to fund neuro-imaging and extra doctor visit
    • In order to get more data out of the trial

We are almost filling the role of an early stage investor (in some cases).

Giving foundation money to drug companies must be a challenge for people giving money to the foundation to take, but we are pushing the envelope in order to do whatever we can to accelerate the finding of a cure.

For more information on the talk, go here.

Posted in

Braden Kelley

Braden Kelley is a Design Thinking, Innovation and Transformation Consultant, a popular innovation speaker and workshop leader, and helps companies use Human-Centered Change™ to beat the 70% change failure rate. He is the author of Charting Change from Palgrave Macmillan and Stoking Your Innovation Bonfire from John Wiley & Sons. Braden has been advising companies since 1996, while living and working in England, Germany, and the United States. Braden earned his MBA from top-rated London Business School. Follow him on Twitter and Linkedin.

NEVER MISS ANOTHER NEWSLETTER!

Categories

LATEST BLOGS

How to Win in the Disruptive Economy: A New Playbook for Success

By Greg Heist | June 4, 2021

Leo Tilman and Charles Jacoby write in their book Agility: How to Navigate the Unknown and Seize Opportunity in a…

Read More

DEVELOPING A HUMAN-CENTRIC FUTURE-FIT FOCUS

By Janet Sernack | May 18, 2021

In a recent article “Organizing for the future: Nine keys to becoming a future-ready company” McKinsey and Co, suggested that…

Read More

Leave a Comment